Internship

Intern – Commercial

Patient-Reported Outcomes Analytics

Posted on 9/3/2024

Gilead Sciences

Gilead Sciences

10,001+ employees

Develops and commercializes biopharmaceuticals

Biotechnology
Healthcare

Compensation Overview

$19 - $55Hourly

No H1B Sponsorship

San Mateo, CA, USA

Must be able to relocate if necessary and work at the designated site for the duration of the internship.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Must be at least 18 years old
  • Must have a minimum GPA of 2.8
  • Authorized to work in the United States without Sponsorship now or in the future or CPT/OPT through your University.
  • Must be currently enrolled as a full-time student at an accredited U.S. based university or college and enrolled in the fall semester after the completion of the internship.
  • Must be enrolled in an advanced degree program.
  • Must be able to complete a 10-12 consecutive week internship between May and August
  • Must be able to relocate if necessary and work at the designated site for the duration of the internship
Responsibilities
  • Conduct an applied project (a.k.a. work) in PRO analytics with your manager’s assistance.
  • Collaborate with your manager on selected ongoing PRO analytics projects.
  • Meet with cross-functional teams to understand the role of PROs in drug development.
  • Participate in selected regular meetings at HEOR and GV&A.
  • Showcase your work with a final presentation (PPT) near the conclusion of your internship.

Gilead Sciences is a biopharmaceutical company that develops and sells medicines for various serious health conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then approved by regulatory authorities before being marketed to healthcare providers, hospitals, and pharmacies. Gilead differentiates itself from competitors through its strong focus on R&D and its commitment to health equity, ensuring that its medicines are accessible to underserved communities. The company's goal is to address unmet medical needs and improve global health by making its treatments available to those who need them most.

Company Stage

IPO

Total Funding

$15.9B

Headquarters

Foster City, California

Founded

1987

Simplify Jobs

Simplify's Take

What believers are saying

  • Gilead's investment in Xilio supports tumor-activated immuno-oncology therapies.
  • Partnership with Terray Therapeutics strengthens Gilead's small-molecule therapies pipeline.
  • Appointment of Dietmar Berger as CMO brings strategic leadership to clinical operations.

What critics are saying

  • Increased competition in HIV market from ViiV Healthcare's expanding portfolio.
  • Regulatory scrutiny over drug pricing, especially in the U.S., poses challenges.
  • Patent expirations could lead to revenue loss from generic competition.

What makes Gilead Sciences unique

  • Gilead's lenacapavir is recognized as a breakthrough in HIV care solutions.
  • Partnership with LEO Pharma enhances Gilead's inflammation research with oral STAT6 programs.
  • Collaboration with Tubulis expands Gilead's oncology portfolio with antibody-drug conjugates.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

INACTIVE